Zhao Y, He Y, Wang W, Cai Q, et al. Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis. Lancet Oncol 2024 Aug 16:S1470-2045(24)00379.
PMID: 39159630